Transient induction of neurotrophin expression using the RNAa system is suggested as a pharmacological approach for several neurological disorders, as reduced neurotrophin expression has been observed in different neurodegenerative and neurodevelopmental disorders [14]. The gene discussed is BDNF; the disease is nervous system disorder.